These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 5195904

  • 1. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J.
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract] [Full Text] [Related]

  • 2. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A, Borgå O, Sjöqvist F.
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract] [Full Text] [Related]

  • 3. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B, Bisetti A, Monzali G.
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM.
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract] [Full Text] [Related]

  • 7. [Concentration and tolerance of INH and PAS in single daily doses. (Preliminary report)].
    Vil'derman AM, Finn ER, Busygina RN, Draganiuk KA, Ezerskiĭ VF, Evgrafova ZA.
    Probl Tuberk; 1965; 43(11):30-4. PubMed ID: 5875728
    [No Abstract] [Full Text] [Related]

  • 8. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM, Kiselova ES.
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H.
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract] [Full Text] [Related]

  • 17. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh, Bilyk MA.
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.